Skip to content

What Is the Less Expensive Option to Ozempic?

5 min read

With the retail price of brand-name Ozempic often exceeding $1,000 per month without insurance, many patients seek more affordable options. Finding what is the less expensive option to Ozempic depends on the intended use, whether for type 2 diabetes or weight management, and can involve a variety of alternative medications and cost-reduction strategies.

Quick Summary

Several affordable alternatives to Ozempic exist, ranging from inexpensive oral medications like Metformin to other injectable GLP-1 agonists with varied costs. Compounded versions of semaglutide are also available at lower price points. Costs vary based on medication, insurance, and discount programs. A healthcare provider can help determine the right and most cost-effective choice.

Key Points

  • Metformin is the lowest-cost oral alternative: As a generic, metformin is significantly cheaper than Ozempic, though it's typically a first-line treatment for diabetes and offers more modest weight loss.

  • Other GLP-1 injections can be less expensive: Medications like Victoza (daily) and Trulicity (weekly) have lower list prices than Ozempic, with potential for greater savings through discount programs.

  • Compounded semaglutide is affordable but unregulated: While offering a much lower cost for the same active ingredient, compounded versions are not FDA-approved and carry quality and safety risks that patients must consider.

  • Oral semaglutide (Rybelsus) is an option for needle-averse patients: Rybelsus offers the same active ingredient as Ozempic in a daily tablet, though its list price is similar.

  • Weight loss-specific drugs like Zepbound and Wegovy may be covered differently: Though their list prices are high, these FDA-approved weight loss medications may have different insurance coverage, potentially making them a more affordable option for those with the appropriate medical conditions.

  • Discount cards and patient assistance programs can reduce Ozempic's cost: Even if sticking with Ozempic, savings cards, discount programs, or patient assistance from the manufacturer can drastically lower the monthly out-of-pocket expense for eligible patients.

In This Article

Ozempic (semaglutide) is a popular medication for managing type 2 diabetes, often used off-label for weight loss, but its high cost is a significant barrier for many. Fortunately, a range of more affordable alternatives exists. These options vary in their active ingredients, mechanisms of action, and, crucially, their price point, making it possible to find a suitable and budget-friendly solution for managing blood sugar or weight.

Low-Cost Oral Medications

For those managing type 2 diabetes, the most budget-friendly options are often older, established oral medications. These are typically available as generics, driving their cost down significantly compared to newer, brand-name drugs.

  • Metformin: Considered a first-line treatment for type 2 diabetes, generic metformin is one of the most affordable prescription drugs available, often costing between $10 and $30 for a 30-day supply without insurance. It works by decreasing glucose production in the liver and improving insulin sensitivity. While it can also lead to modest weight loss, it is not a weight-loss drug itself.
  • Sulfonylureas (e.g., glipizide, glimepiride): These medications increase insulin production from the pancreas and are very inexpensive, costing around $10 for a three-month supply. However, they carry a higher risk of hypoglycemia (low blood sugar) than Ozempic and may cause weight gain.
  • Rybelsus: Rybelsus is an oral tablet formulation of semaglutide, the same active ingredient as Ozempic. While its list price is similar to Ozempic's, costing close to $1,000 per month without insurance, its daily oral format may be preferred by some. Cost-saving programs can help lower the out-of-pocket expense for eligible patients.

Alternative Injectable GLP-1 Agonists

If an injectable GLP-1 agonist is the preferred treatment, other options may offer a slightly better price or different insurance coverage possibilities compared to Ozempic.

  • Victoza (liraglutide): This daily injectable GLP-1 is often less expensive than Ozempic, especially with discount programs or for those with specific insurance plans. Victoza's list price is lower than Ozempic, and generic liraglutide may be available at an even lower cost.
  • Trulicity (dulaglutide): A once-weekly injectable, Trulicity is a GLP-1 agonist that works similarly to Ozempic. While list prices are comparable, insurance coverage varies, and savings cards can reduce the monthly cost for eligible individuals.
  • Compounded Semaglutide: Some pharmacies offer compounded versions of semaglutide, which contain the same active ingredient as Ozempic but at a significantly lower cost. It is crucial to understand that these products are not FDA-approved, meaning their safety, effectiveness, and manufacturing quality are not regulated by the FDA. This option carries risks that patients should discuss thoroughly with their doctor.

Weight Loss Specific Medications

For those primarily seeking weight loss, several medications are FDA-approved for this purpose and may be less expensive or have different insurance coverage than Ozempic, which is only FDA-approved for diabetes and heart risk reduction.

  • Wegovy (semaglutide): Wegovy is a higher-dose, FDA-approved version of semaglutide specifically for weight management. Its list price is generally higher than Ozempic, but insurance may cover it for weight loss where Ozempic would not be, potentially making it cheaper depending on your plan.
  • Zepbound (tirzepatide): With the same active ingredient as Mounjaro, Zepbound is FDA-approved for chronic weight management. It's a dual GIP/GLP-1 agonist, which can result in more significant weight loss than Ozempic for some patients. Savings offers can bring the cost down, with the manufacturer offering a direct-to-consumer vial and syringe option.
  • Contrave (bupropion/naltrexone): This oral combination medication helps reduce appetite and cravings. It can be an affordable option with certain savings programs.

Strategies for Reducing Ozempic Costs

If a provider determines Ozempic is the best option, several strategies can help manage the cost:

  • Manufacturer Savings Cards: For commercially insured patients, the manufacturer Novo Nordisk offers a savings card that can reduce the monthly cost to as little as $25. Eligibility requires existing insurance coverage that includes Ozempic.
  • Patient Assistance Programs (PAPs): Novo Nordisk also has a Patient Assistance Program that may provide Ozempic for free to uninsured patients with low incomes who meet eligibility requirements.
  • Pharmacy Discount Programs: Free coupons from services like SingleCare or GoodRx can lower the out-of-pocket cost for Ozempic at participating pharmacies. Some direct-to-consumer pharmacy services also offer reduced prices for self-pay customers.
  • Health Savings Account (HSA) or Flexible Spending Account (FSA): Using pre-tax funds from an HSA or FSA for prescription medications can help lower the overall cost.
  • Discussing Insurance Coverage: For diabetes management, insurance plans typically cover Ozempic. If it is not covered, a provider can sometimes file an appeal with the insurance company to argue for medical necessity.

Comparison of Ozempic Alternatives

Medication (Active Ingredient) Typical Monthly Cost (Without Insurance) FDA-Approved Use(s) Dosage Form Key Difference
Ozempic (semaglutide) ~$1,000+ Type 2 Diabetes Once-weekly Injection Reference point for comparison
Metformin (generic) ~$10-$30 Type 2 Diabetes Oral Tablet Very low cost, foundational therapy
Victoza (liraglutide) ~$600-$800 Type 2 Diabetes Once-daily Injection Less expensive than Ozempic, requires daily dose
Trulicity (dulaglutide) ~$500-$700 Type 2 Diabetes Once-weekly Injection Another once-weekly GLP-1 option
Rybelsus (semaglutide) ~$998 Type 2 Diabetes Daily Oral Tablet Same active ingredient as Ozempic but oral
Compounded Semaglutide Starts ~$199 Not FDA-approved Varies (often injectable vial) Lower cost, but not FDA-regulated
Wegovy (semaglutide) ~$1,349 Weight Management Once-weekly Injection Higher dose, FDA-approved for weight loss
Zepbound (tirzepatide) ~$1,086 Weight Management Once-weekly Injection Dual GIP/GLP-1 agonist for potentially greater weight loss
Contrave (bupropion/naltrexone) ~$99 with program Weight Management Oral Tablet Oral, non-GLP-1 option for appetite control

Conclusion

Finding a less expensive alternative to Ozempic involves exploring a range of options with a healthcare provider. For those focused on type 2 diabetes management, generic oral medications like metformin or other GLP-1s like Victoza and Trulicity can offer significant cost savings. For weight management, FDA-approved options like Wegovy and Zepbound, or oral alternatives like Contrave, may have more favorable insurance coverage. It is essential to weigh the cost, side effects, and mechanism of action with a doctor to determine the most appropriate and affordable treatment path for individual health needs. Utilizing manufacturer programs, discount cards, and other financial assistance resources can further help manage the cost of these medications.

The Importance of Medical Consultation

Because each medication has a unique profile regarding efficacy, side effects, and approval status, consulting a healthcare provider is paramount before making any changes. They can provide guidance tailored to your medical history and weight loss or diabetes management goals. For a deeper look into treatment options, the National Institutes of Health offers extensive resources: National Institutes of Health (NIH) | (.gov).

Frequently Asked Questions

No, Ozempic is only FDA-approved for type 2 diabetes and cardiovascular risk reduction, and insurance plans typically do not cover its off-label use for weight loss.

Currently, no generic version of Ozempic (semaglutide) is FDA-approved. Cheaper options are either different medications or unregulated compounded versions.

Eligible patients can use manufacturer savings cards, patient assistance programs for those with low income, or pharmacy discount coupons from services like GoodRx to reduce the cost.

Compounded semaglutide is a version of the active ingredient mixed by pharmacies, not evaluated or approved by the FDA. While cheaper, it lacks the FDA oversight of brand-name Ozempic regarding safety and effectiveness.

Metformin is a very inexpensive oral alternative for type 2 diabetes, while Rybelsus is an oral version of semaglutide with a comparable list price to Ozempic.

Wegovy has a higher list price than Ozempic but is FDA-approved for weight management, so insurance coverage may be more likely for that purpose, potentially making it a cheaper out-of-pocket expense.

Non-GLP-1 options include oral medications like Contrave (bupropion/naltrexone) and Orlistat, which work differently to control appetite and block fat absorption.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.